India Showcasing Drug Industry As Quality Source To Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
India, its drug industry under fire from regulators in developed countries for alleged lapses in quality-production standards, is attempting to show regulators in emerging markets a different picture.